LXRX Q4 2016 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23M-81.9% YoY

Gross Profit

-$17M-75.4% margin

Operating Income

-$31M-136.0% margin

Net Income

-$32M-140.7% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-16.9%

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$49M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$476M

Total Liabilities

$318M

Stockholders' Equity

$157M

Cash & Equivalents

$347M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$127M	-81.9%
Gross Profit	-$17M	$97M	-117.9%
Operating Income	-$31M	$88M	-135.5%
Net Income	-$32M	$87M	-137.4%